A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future

by Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ
Published 2019-09-01

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

by Ward K, Citrome L
Published 2019-01-01

Schizophrenia relapse, patient considerations, and potential role of lurasidone

by Citrome L
Published 2016-08-01

Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults

by Faden J, Citrome L
Published 2019-08-01

An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder

by Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D
Published 2021-09-01

Lack of tolerable treatment options for patients with schizophrenia

by Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P
Published 2015-12-01

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm

by Citrome L, Du Y, Weiden PJ
Published 2019-09-01

Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents

by Citrome L
Published 2013-05-01

Role of sublingual asenapine in treatment of schizophrenia

by Citrome L
Published 2011-05-01

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

by Citrome L
Published 2018-10-01

Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder

by Citrome L, Landbloom R, Chang C, Earley W
Published 2017-12-01

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

by Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L
Published 2018-08-01